OGT and neoplasm: In future studies, it will be interesting to determine whether the content of OGT and O-GlcNAc in tumor tissues, urine, or blood could represent useful predictive biomarkers of disease progression and clinical outcomes in advanced UCB patients treated with chemotherapeutic agents.